At Pathway Diagnostics, we believe that every diagnosis tells a story — one that deserves accuracy, clarity, and care. Our subspecialized team of American Board certified pathologists and qualified technologists delivers advanced diagnostic solutions across multiple disciplines, using cutting-edge technology and evidence-based medicine to support the best possible clinical outcomes.
Pathway Diagnostics provides specialized histopathologic, immunohistochemical, and molecular testing support for clinical research and sponsored trials. Our laboratory is equipped with state-of-the-art digital pathology systems, automated immunostaining platforms, and advanced molecular technologies to facilitate biomarker validation, companion diagnostic studies, and translational research.
All analyses are supervised by American Board-certified pathologists, ensuring accuracy, reproducibility, and compliance with international quality standards (CAP-aligned).
We collaborate closely with investigators, CROs, and pharmaceutical partners to transform complex tissue data into meaningful scientific insights.
Comprehensive evaluation of esophageal, gastric, small intestinal, and colorectal diseases — from inflammatory and infectious conditions to complex malignancies. Our team integrates histopathology, immunostaining, and molecular insights to ensure confident, actionable diagnoses.
Expert diagnostic evaluation of hematologic diseases involving bone marrow, lymph nodes, and peripheral blood. We combine morphology, flow cytometry, immunohistochemistry, and molecular techniques to deliver precise disease classification and prognostic interpretation.
Detailed assessment of liver biopsies, cholangiopathies, and neoplastic lesions of the liver and pancreas. Our pathologists integrate microscopic, serologic, and molecular data to provide clinically relevant, high-accuracy results.
Subspecialty interpretation of prostate, bladder, kidney, and testicular specimens with expert tumor grading, staging, and molecular profiling — supporting personalized patient management and therapeutic planning.
Specialized evaluation of benign and malignant lesions of the oral cavity, nasopharynx, salivary glands, and thyroid. Advanced immunohistochemical and molecular studies ensure diagnostic accuracy and clinical correlation.
Expert diagnosis of inflammatory, infectious, and neoplastic skin diseases. Each specimen is interpreted in close clinical context to ensure clarity and consistency in reporting.
Comprehensive evaluation of benign and malignant bone and soft tissue lesions, including sarcomas. Our integrated immunohistochemical and molecular approach ensures accurate classification and guidance for therapy.
Accurate and timely diagnosis of breast and gynecologic specimens, including endometrial, cervical, and ovarian pathology. We integrate morphologic, immunohistochemical, and molecular data to support personalized care.
Expert interpretation of FNA samples from multiple organ systems, with on-site adequacy assessment and correlation with histopathology and imaging studies for comprehensive diagnostic insight.
At Pathway Diagnostics, we go beyond routine testing.
Our advanced ancillary services combine cutting-edge technology with expert interpretation to deliver results that truly guide patient care. Every test is performed with precision, speed, and reliability—because every detail matters.
Our automated IHC systems provide highly sensitive and specific staining for a wide range of diagnostic and predictive biomarkers. From cancer classification to treatment selection, our IHC service ensures accurate answers clinicians can trust.
Sometimes, the smallest detail makes the biggest difference. Our comprehensive menu of special stains helps highlight microorganisms, pigments, and structural tissue components—adding valuable context to every diagnosis.
Fast, detailed, and dynamic—our flow cytometry service delivers crucial insights for blood and bone marrow disorders. We offer complete immunophenotyping and minimal residual disease detection to support rapid and confident hematologic diagnoses.
Harnessing the power of genetics, our molecular diagnostics platform identifies key mutations, fusions, and biomarkers that drive disease. Using PCR and next-generation sequencing (NGS) technologies, we enable truly personalized, precision-driven care.
Our cytogenetic testing reveals chromosomal and structural abnormalities that guide diagnosis and prognosis in cancers and genetic conditions. Through techniques such as karyotyping and FISH, we help clinicians see the complete genetic picture.
